News & Press Releases

Mintz attorneys successfully represented adidas America Inc. in arguing against certification of a class action suit involving one of the company’s popular running shoes. The U.S. District Judge ruled the plaintiff did not present sufficient evidence that adidas’ Springblade shoes were defective.  

Attorneys from Mintz represented Myriad Genetics, Inc. in its acquisition of Assurex Health, an informatics-based precision medicine company providing treatment decision support to health care providers for mental health patients.

Jeremy D. Glaser, Co-Chair of the Mintz Venture Capital & Emerging Companies Practice, is moderating a panel discussion at ACG San Diego’s “What’s Brewing in the Craft Beer & Distilled Spirits Space – Trends and Updates” program.

ML Strategies Executive VP & Director of Operations Alex Hecht and Manager of Government Relations Eli Greenspan authored this HFMA Advisor article discussing the impact that states transitioning their Medicaid populations into managed care has had on individuals with traumatic brain injuries.

Jeffrey A. Moerdler, Head of MIntz's Real Estate and Communications Practices, is participating in a panel discussion at the Washington, DC & Mid-Atlantic Data Center Summit. Mr. Moerdler will discuss the factors affecting big-picture data center decision making.

Larry Freedman, a health care and life sciences litigator and Mintz Member, is quoted in a Bloomberg BNA Health Care Fraud Report article on how current fraud investigations being conducted by U.S. attorneys could be impacted as the start of a new presidential administration approaches.